Does Horizon Blue Cross Blue Shield of New Jersey Cover Wegovy?
The verdict
Conditional on most plans
Horizon Blue Cross Blue Shield of New Jersey may cover Wegovy for weight management with prior authorization (BMI 30 or higher, or 27 with a comorbidity, with documented prior weight-loss attempts), but coverage is plan-dependent and per-plan drug-tier is not publicly published. This is a more favorable posture than neighboring Independence Blue Cross, which excluded weight-loss GLP-1s outright in 2025. Verify on Horizon's formulary or drug-lookup tool.
Coverage is set by your specific plan and formulary. This is a research summary — always confirm with Horizon Blue Cross Blue Shield of New Jersey using your member ID.
Key facts
Unlike neighboring Independence Blue Cross (which excluded weight-loss GLP-1s in January 2025), Horizon BCBS of New Jersey may still cover Wegovy for weight management with PA on applicable commercial plans.
Independence Blue Cross member communications; Horizon BCBS NJ formulary
Wegovy's list price is $1,349/month; Novo Nordisk announced a reduction to approximately $675/month effective January 1, 2027.
Novo Nordisk press release, 2026
The Medicare GLP-1 Bridge launches July 1, 2026, giving eligible Medicare beneficiaries Wegovy weight-loss access at $50/month outside Part D — not counting toward the $2,100 OOP cap.
CMS.gov, Medicare GLP-1 Weight Loss Drug Access Program
Medicare vs. commercial coverage
Whether Horizon Blue Cross Blue Shield of New Jersey covers Wegovy depends heavily on which kind of plan you hold. They follow completely different rules — here's each one, side by side.
Medicare
Part D & Advantage plans
Medicare Part D cannot cover Wegovy for weight loss by statute — this applies to all Horizon Medicare plans. Horizon Medicare Advantage plans can cover Wegovy for the cardiovascular risk-reduction indication (FDA-approved for adults with established CVD who are overweight or obese) with prior authorization. The Medicare GLP-1 Bridge launches July 1, 2026, giving eligible Medicare beneficiaries weight-loss access to Wegovy at $50/month through December 31, 2027 — this operates outside Part D, so the $50 does not count toward the $2,100 OOP cap or TrOOP. Extra Help cannot be applied to Bridge copays. NovoCare savings card is not available to Medicare beneficiaries.
Commercial / Employer
Group & marketplace plans
Horizon BCBS of New Jersey may cover Wegovy for weight management on commercial and employer plans where medical necessity criteria are met, including BMI 30 or higher, or BMI 27 or higher with at least one weight-related comorbidity (hypertension, type 2 diabetes, dyslipidemia, or obstructive sleep apnea), and documented prior weight-loss attempts. Coverage is plan-dependent — not all Horizon commercial plans include the anti-obesity benefit, and individual-market ACA plans generally exclude Wegovy for weight loss. Per-plan drug tier and cost-share are not publicly published at the drug level; members should verify their specific plan via Horizon's drug-lookup tool. NJ Medicaid GLP-1 obesity coverage is state-dependent; verify current NJ Medicaid status via NJ FamilyCare. Commercially insured Horizon members whose plan covers Wegovy may use the NovoCare savings card at $25/month (max $100 per 28-day supply; not available to Medicare or Medicaid beneficiaries).
The 5 boxes you must tick to get approved
Commercial plans that will consider Wegovy require prior authorization. Check off what applies to you to see how close you are — this is a guide, not a guarantee of approval.
Meet all 5 and you have a documented case for approval. Missing any one is the most common reason requests are denied.
Your cost, three ways
What Wegovy actually costs you swings enormously depending on how it's covered. Here's the realistic range.
Paying cash
$1,349/month (Novo Nordisk published list price for a 28-day supply). NovoCare self-pay: approximately $349/month for standard injection doses after an introductory period through December 31, 2026.
List price with no coverage — before any manufacturer savings card.
With coverage
Plan-specific cost-share where covered — not publicly published. Confirm your specific cost-share on Horizon's drug-lookup tool or member portal. NovoCare savings card: commercially insured Horizon members whose plan covers Wegovy may pay as little as $25/month (max $100 per 28-day supply). Not available to Medicare or Medicaid beneficiaries.
Typical monthly copay once prior authorization is approved.
Bridge program
Medicare GLP-1 Bridge: $50/month fixed copay for eligible Medicare beneficiaries, launching July 1, 2026, through December 31, 2027. Operates outside Part D — does not count toward the $2,100 OOP cap, TrOOP, or Extra Help. Provider must attest eligibility at initiation.
Reduced copay through the assistance program, where eligible.
All cost figures are estimates. Actual cost-share varies by plan tier, deductible phase, and pharmacy — confirm with your Horizon plan and pharmacist before starting treatment.
Check YOUR exact coverage in 3 steps
General answers only get you so far. Here's how to confirm your own plan's decision in a few minutes.
- 1
Search Horizon's drug-lookup tool for your specific plan
Go to horizon-bcbsnj.com and use the formulary or drug-lookup tool with your specific member ID and plan. Search for 'Wegovy' or 'semaglutide 2.4 mg' to confirm whether your plan includes the anti-obesity benefit, the drug's tier, and prior authorization requirements.
- 2
Confirm the anti-obesity benefit with your HR or plan summary
Even if Horizon's formulary shows Wegovy as covered, individual employer plans may exclude anti-obesity medications. Review your Summary of Benefits and Coverage or ask your HR benefits team whether weight-loss drugs are included in your specific employer plan.
- 3
Work with your prescriber on prior authorization
If your plan covers Wegovy, your doctor will submit a PA to Horizon. Gather documentation: BMI measurement, relevant comorbidities, evidence of prior weight-loss efforts, and lifestyle program participation. Follow up with your prescriber before each renewal to track weight-loss progress needed for reauthorization.
Options if Horizon Blue Cross Blue Shield of New Jersey won't cover Wegovy
A denial isn't the end of the road. These are the paths people commonly explore next — discuss any of them with your prescriber.
Independence Blue Cross contrast
If you have Independence Blue Cross (the neighboring Philadelphia-region Blue plan), the situation is more restrictive: Independence excluded weight-loss GLP-1s across fully insured group and individual plans effective 1/1/2025. Horizon has not issued an equivalent blanket exclusion, making it one of the more favorable Blue plans in the region for Wegovy weight-loss coverage.
NovoCare self-pay program
Novo Nordisk's NovoCare Pharmacy offers Wegovy at approximately $349/month for patients without coverage. An introductory rate of approximately $199/month applies to the 0.25 and 0.5 mg doses through December 31, 2026. List price is announced to drop to approximately $675/month effective January 1, 2027.
Compounded semaglutide
Compounded semaglutide is available without insurance for patients who cannot access covered Wegovy. See the Curex offer below. Compounded medications are not the same as Wegovy and have not been approved by the FDA.
These options are listed for information only — your own clinician decides what is appropriate for you.
❓Frequently Asked Questions
Horizon may cover Wegovy for weight loss with prior authorization on commercial plans where the anti-obesity benefit is included — requiring BMI 30 or higher (or 27 with a comorbidity) and documented prior weight-loss efforts. Coverage is plan-dependent, so not every Horizon commercial plan includes it. ACA/individual-market plans generally exclude Wegovy for weight loss. Verify your specific plan on Horizon's drug-lookup tool at horizon-bcbsnj.com before assuming coverage.
Horizon BCBS of New Jersey and Independence Blue Cross are neighboring Blue plans in the same metro area but with different Wegovy stances. Independence excluded weight-loss GLP-1 coverage entirely on fully insured group and individual plans effective January 1, 2025. Horizon has not issued an equivalent blanket exclusion and may still cover Wegovy for weight management with PA where the plan includes the anti-obesity benefit. For weight-loss seekers, Horizon is the more favorable of the two — though coverage is still plan-dependent.
Horizon generally requires BMI 30 or higher (or 27 with a weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidemia, or sleep apnea), documented prior weight-loss attempts, and participation in a structured lifestyle program. Your prescriber submits the PA with supporting clinical records. Renewal typically requires demonstrated weight-loss progress. Because specific criteria are not publicly published at the drug level, confirm current requirements with Horizon member services or your prescriber.
No. Medicare Part D cannot cover Wegovy for weight loss by statute — this applies to all Horizon Medicare plans regardless of other plan features. Horizon Medicare Advantage plans can cover Wegovy for the cardiovascular risk-reduction indication in members with established CVD. The Medicare GLP-1 Bridge (launching July 1, 2026) provides weight-loss access at $50/month outside Part D for eligible beneficiaries — verify eligibility criteria with your prescriber.
Commercially insured Horizon members whose plan covers Wegovy may use the NovoCare savings card to pay as little as $25/month (up to $100 savings per 28-day supply). The card is not available to Medicare or Medicaid beneficiaries. NJ Medicaid beneficiaries cannot use the savings card. If your Horizon commercial plan covers Wegovy and you are commercially insured, the NovoCare card can meaningfully reduce your out-of-pocket cost.
Related Articles
Does Horizon BCBS of New Jersey Cover Mounjaro? 2026 | Curex
Horizon BCBS of NJ covers Mounjaro for T2D with prior auth — not weight loss. NJ Medicaid's weight-loss GLP-1 coverage applies to Zepbound, not Mounjaro.
Read moreDoes BCBS North Carolina Cover Wegovy? 2026 | Curex
BCBS North Carolina: NC State Health Plan dropped weight-loss GLP-1s in 2024; NC Medicaid removed obesity coverage October 2025. Verify your specific plan.
Read moreDoes Horizon BCBS of New Jersey Cover Ozempic? 2026 | Curex
Horizon BCBS NJ covers Ozempic for T2D with PA — not weight loss. NJ FamilyCare Medicaid covers T2D. NovoCare $25/mo for commercial T2D. Verify on Horizon.
Read moreDoes BCBS of Arizona Cover Wegovy? 2026 Guide | Curex
BCBS of Arizona covers Wegovy only where your employer opted in; formulary not published. Verify via drug-lookup and confirm with HR first.
Read moreDoes Blue Cross Blue Shield of Illinois Cover Wegovy? | Curex
BCBS Illinois (HCSC) covers Wegovy only where your employer opts in. ACA plans exclude it. Formulary not public — verify on your plan's drug-lookup tool.
Read moreDoes BCBS Alabama Cover Wegovy? 2026 Guide | Curex
BCBS Alabama Wegovy coverage is employer-dependent and unpublished. Alabama Medicaid excludes obesity GLP-1s. How to verify your specific plan.
Read moreWhether or not Horizon Blue Cross Blue Shield of New Jersey covers Wegovy, there's a path that skips insurance
Horizon may cover Wegovy with prior authorization, but coverage is plan-dependent. For patients whose plan does not include the anti-obesity benefit, Curex offers compounded semaglutide from $49/mo (compounded tirzepatide from $149/mo) at getcurex.com/cl/glp — no insurance, no prior authorization. Compounded semaglutide is not the same medication as Wegovy. Prescription required, subject to provider review.
- Medication + free shipping
- 24/7 provider access
- Medical intake & prescription review
Compounded semaglutide and tirzepatide are not the same medications as Wegovy and are not branded or FDA-approved products. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.
This content is for informational purposes only and does not constitute medical, financial, or insurance advice. Coverage rules, prior-authorization criteria, and copay amounts change frequently and vary by plan, formulary tier, and effective date — always verify current benefits directly with Horizon Blue Cross Blue Shield of New Jersey before making any decision. Consult a licensed healthcare provider and your plan administrator for guidance specific to your situation. Curex offers compounded semaglutide and tirzepatide, which are not the same medications as Wegovy and are not branded or FDA-approved products; prescription required, subject to provider review. Compounded medications have not been approved by the FDA and the FDA has not evaluated their safety or efficacy.